Naftifina (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Naftifina" in Italian language version.

refsWebsite
Global rank Italian rank
4th place
9th place
799th place
22nd place
2nd place
7th place
447th place
644th place

doi.org

dx.doi.org

fda.gov

nih.gov

ncbi.nlm.nih.gov

  • G. Petranyi, NS. Ryder; A. Stütz, Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase., in Science, vol. 224, n. 4654, Giu 1984, pp. 1239-41, PMID 6547247.
  • NS. Ryder, MC. Dupont, Inhibition of squalene epoxidase by allylamine antimycotic compounds. A comparative study of the fungal and mammalian enzymes., in Biochem J, vol. 230, n. 3, Set 1985, pp. 765-70, PMID 3877503.
  • NS. Ryder, G. Seidl; PF. Troke, Effect of the antimycotic drug naftifine on growth of and sterol biosynthesis in Candida albicans., in Antimicrob Agents Chemother, vol. 25, n. 4, aprile 1984, pp. 483-7, PMID 6375557.
  • NH. Georgopapadakou, BA. Dix; SA. Smith; J. Freudenberger; PT. Funke, Effect of antifungal agents on lipid biosynthesis and membrane integrity in Candida albicans., in Antimicrob Agents Chemother, vol. 31, n. 1, gennaio 1987, pp. 46-51, PMID 3551826.
  • A. Kecskes, P. Jahn, [Assessment of the antiphlogistic effect of naftifin-HCl in the UV-B erythema test]., in Hautarzt, vol. 40, n. 3, marzo 1989, pp. 158-60, PMID 2654080.
  • EG. Evans, IG. James; RA. Seaman; MD. Richardson, Does naftifine have anti-inflammatory properties? A double-blind comparative study with 1% clotrimazole/1% hydrocortisone in clinically diagnosed fungal infection of the skin., in Br J Dermatol, vol. 129, n. 4, Ott 1993, pp. 437-42, PMID 8217759.
  • AH. Faruqi, KA. Khan; AA. Qazi; TS. Haroon, In vitro antifungal activity of naftifine: (SN 105-843 GEL) against dermatophytes., in J Pak Med Assoc, vol. 31, n. 12, Dic 1981, pp. 279-82, PMID 6806496.
  • A. Georgopoulos, G. Petranyi; H. Mieth; J. Drews, In vitro activity of naftifine, a new antifungal agent., in Antimicrob Agents Chemother, vol. 19, n. 3, marzo 1981, pp. 386-9, PMID 7247366.
  • R. Czok, Preclinical evaluation of Exoderil (naftifine). Part II. Mechanism of action, absorption, metabolism and excretion, in Mykosen, n. 30, 1987, pp. 32-7, PMID 3550458.
  • RB. Stoughton, J. Sefton; L. Zeleznick, In vitro and in vivo cutaneous penetration and antifungal activity of naftifine., in Cutis, vol. 44, n. 4, Ott 1989, pp. 333-5, PMID 2805810.
  • U. Ganzinger, A. Stutz; G. Petranyi; A. Stephen, Allylamines: topical and oral treatment of dermatomycoses with a new class of antifungal agents., in Acta Derm Venereol Suppl (Stockh), vol. 121, 1986, pp. 155-60, PMID 3459341.
  • R. Weiss, H. Krauss; M. Kaps, [Electron microscopy demonstration of the capsule of Cryptococcus neoformans]., in Mykosen, vol. 30, n. 2, febbraio 1987, pp. 57-63, PMID 3553928.
  • S. Nolting, G. Weidinger, [Naftifin in severe dermatomycosis--controlled comparison of efficacy with econazole]., in Mykosen, vol. 28, n. 2, febbraio 1985, pp. 69-76, PMID 3885027.
  • LE. Millikan, WK. Galen; GB. Gewirtzman; SN. Horwitz; RK. Landow; LT. Nesbitt; HL. Roth; J. Sefton; RM. Day, Naftifine cream 1% versus econazole cream 1% in the treatment of tinea cruris and tinea corporis., in J Am Acad Dermatol, vol. 18, 1 Pt 1, gennaio 1988, pp. 52-6, PMID 3279083.
  • CT. Lee, YC. Giam; T. Tan, The use of naftifine (Exoderil) cream in the treatment of dermatophytosis., in Singapore Med J, vol. 28, n. 5, Ott 1987, pp. 429-31, PMID 3324355.
  • K. Meinicke, C. Striegel; G. Weidinger, [Treatment of dermatomycosis with naftifin. Therapeutic effectiveness following once and twice daily administration]., in Mykosen, vol. 27, n. 12, Dic 1984, pp. 608-14, PMID 6395017.
  • PJ. Haas, H. Tronnier; G. Weidinger, [Naftifin in foot mycoses. Double-blind therapeutic comparison with clotrimazole]., in Mykosen, vol. 28, n. 1, gennaio 1985, pp. 33-40, PMID 3883160.
  • A. Bojanovsky, P. Haas, [Antimycotic effect of naftifin in tinea pedis. Comparative double-blind study with bifonazole]., in Fortschr Med, vol. 103, n. 25, Lug 1985, pp. 677-9, PMID 3897005.
  • F. Klaschka, H. Gartmann; G. Weidinger, [The antifungal agent naftifin. Placebo-controlled therapeutic comparison in tinea pedis]., in Z Hautkr, vol. 59, n. 18, Set 1984, pp. 1218-26, PMID 6388170.
  • EB. Smith, K. Wiss; JM. Hanifin; RE. Jordon; RP. Rapini; AE. Lasser; MB. Kirschenbaum; LE. Millikan; LC. Parish; MJ. Rapaport, Comparison of once- and twice-daily naftifine cream regimens with twice-daily clotrimazole in the treatment of tinea pedis., in J Am Acad Dermatol, vol. 22, 6 Pt 1, Giu 1990, pp. 1116-7, PMID 2370340.
  • EB. Smith, DL. Breneman; RF. Griffith; AA. Hebert; JG. Hickman; JM. Maloney; LE. Millikan; VI. Sulica; SH. Dromgoole; J. Sefton, Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis., in J Am Acad Dermatol, vol. 26, n. 1, gennaio 1992, pp. 125-7, PMID 1732321.
  • Naftifine cream 1% versus clotrimazole cream 1% in the treatment of tinea pedis. Naftifine Podiatric Study Group., in J Am Podiatr Med Assoc, vol. 80, n. 6, Giu 1990, pp. 314-8, PMID 2189989.
  • H. Senff, S. Tholen; W. Stieler; D. Reinel; BM. Hausen, Allergic contact dermatitis to naftifine. Report of two cases., in Dermatologica, vol. 178, n. 2, 1989, pp. 107-8, PMID 2522401.
  • E. Hoting, B. Küchmeister; BM. Hausen, [Contact allergy to the antifungal agent naftifin]., in Derm Beruf Umwelt, vol. 35, n. 4, pp. 124-7, PMID 2959458.
  • JJ. Goday, M. González-Güemes; I. Yanguas; R. Ilardia; R. Soloeta, Allergic contact dermatitis from naftifine in a child without cross-reaction to terbinafine., in J Eur Acad Dermatol Venereol, vol. 11, n. 1, Lug 1998, pp. 72-3, PMID 9731972.
  • M. Corazza, MM. Lauriola; A. Virgili, Allergic contact dermatitis to naftifine., in Contact Dermatitis, vol. 53, n. 5, novembre 2005, pp. 302-3, DOI:10.1111/j.0105-1873.2005.0654d.x, PMID 16283912.
  • C. Willa-Craps, M. Wyss; P. Elsner, Allergic contact dermatitis from naftifine., in Contact Dermatitis, vol. 32, n. 6, Giu 1995, pp. 369-70, PMID 7554894.
  • R. Sannerstedt, P. Lundborg; BR. Danielsson; I. Kihlström; G. Alván; B. Prame; E. Ridley, Drugs during pregnancy: an issue of risk classification and information to prescribers., in Drug Saf, vol. 14, n. 2, febbraio 1996, pp. 69-77, PMID 8852521.

oadoi.org